OTLK icon

Outlook Therapeutics
OTLK

Overview Fund Activity

15 hedge funds and large institutions have $21.1M invested in Outlook Therapeutics in 2016 Q2 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
15
Holders Change
+15
Holders Change %
–
% of All Funds
0.4%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
15
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SM
1
Sabby Management
Florida
$7.04M
2
PA
2
Perceptive Advisors
New York
$4.46M
3
CAM
3
Cormorant Asset Management
Massachusetts
$3.49M
4
ACA
4
Avoro Capital Advisors
New York
$1.59M
5
SFM
5
Sphera Funds Management
Israel
$881K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
SM
1
Sabby Management
Florida
$7.04M 2,068,968 +2,068,968 New
PA
2
Perceptive Advisors
New York
$4.46M 1,312,763 +1,312,763 New
CAM
3
Cormorant Asset Management
Massachusetts
$3.49M 1,027,216 +1,027,216 New
ACA
4
Avoro Capital Advisors
New York
$1.59M 466,667 +466,667 New
SFM
5
Sphera Funds Management
Israel
$881K 259,000 +259,000 New
Marshall Wace
6
Marshall Wace
United Kingdom
$851K 250,200 +250,200 New
ACP
7
Acuta Capital Partners
California
$828K 243,391 +243,391 New
PC
8
PointState Capital
New York
$680K 200,000 +200,000 New
JG
9
Jefferies Group
New York
$540K 158,695 +158,695 New
Millennium Management
10
Millennium Management
New York
$300K 88,150 +88,150 New
Hudson Bay Capital Management
11
Hudson Bay Capital Management
Connecticut
$213K 62,500 +62,500 New
MIM
12
Monashee Investment Management
Massachusetts
– – – –
Morgan Stanley
13
Morgan Stanley
New York
$34K 10,000 +10,000 New
UBS Group
14
UBS Group
Switzerland
$5K 1,500 +1,500 New
TRCT
15
Tower Research Capital (TRC)
New York
$2K 600 +600 New
Wells Fargo
16
Wells Fargo
California
$0 100 +100 New